HU0800031D0 - Method for stabilization of s-nitrosoglutathione and composition prepared by the same - Google Patents

Method for stabilization of s-nitrosoglutathione and composition prepared by the same

Info

Publication number
HU0800031D0
HU0800031D0 HU0800031A HUP0800031A HU0800031D0 HU 0800031 D0 HU0800031 D0 HU 0800031D0 HU 0800031 A HU0800031 A HU 0800031A HU P0800031 A HUP0800031 A HU P0800031A HU 0800031 D0 HU0800031 D0 HU 0800031D0
Authority
HU
Hungary
Prior art keywords
nitrosoglutathione
stabilization
same
composition prepared
prepared
Prior art date
Application number
HU0800031A
Other languages
English (en)
Original Assignee
Biotech Hungary Kutato Es Fejl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Hungary Kutato Es Fejl filed Critical Biotech Hungary Kutato Es Fejl
Priority to HU0800031A priority Critical patent/HU0800031D0/hu
Publication of HU0800031D0 publication Critical patent/HU0800031D0/hu
Priority to JP2010542695A priority patent/JP5508286B2/ja
Priority to CN2009801077972A priority patent/CN101969922B/zh
Priority to EP09702422.8A priority patent/EP2252260B1/en
Priority to DK09702422.8T priority patent/DK2252260T3/en
Priority to KR1020107017003A priority patent/KR101601989B1/ko
Priority to BRPI0906874-0A priority patent/BRPI0906874A2/pt
Priority to US12/863,816 priority patent/US8404266B2/en
Priority to HUE09702422A priority patent/HUE025573T2/hu
Priority to PCT/HU2009/000004 priority patent/WO2009090439A2/en
Priority to ES09702422.8T priority patent/ES2538338T3/es
Priority to PT97024228T priority patent/PT2252260E/pt
Priority to CN2013102937033A priority patent/CN103417973A/zh
Priority to CA2712299A priority patent/CA2712299C/en
Priority to PL09702422T priority patent/PL2252260T3/pl
Priority to HK11108321.0A priority patent/HK1153944A1/xx
Priority to HRP20150578TT priority patent/HRP20150578T1/hr
Priority to CY20151100493T priority patent/CY1116359T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU0800031A 2008-01-16 2008-01-16 Method for stabilization of s-nitrosoglutathione and composition prepared by the same HU0800031D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
HU0800031A HU0800031D0 (en) 2008-01-16 2008-01-16 Method for stabilization of s-nitrosoglutathione and composition prepared by the same
PL09702422T PL2252260T3 (pl) 2008-01-16 2009-01-16 Sposób stabilizowania S-nitrozoglutationu i kompozycja wytworzona tym sposobem
HUE09702422A HUE025573T2 (hu) 2008-01-16 2009-01-16 Eljárás s-nitrozoglutation és az eljárással elõállított készítmény
ES09702422.8T ES2538338T3 (es) 2008-01-16 2009-01-16 Método para la estabilización de S-nitrosoglutatión y composición preparada por el mismo
EP09702422.8A EP2252260B1 (en) 2008-01-16 2009-01-16 Method for stabilization of s-nitrosoglutathione and composition prepared by the same
DK09702422.8T DK2252260T3 (en) 2008-01-16 2009-01-16 METHOD FOR STABILIZING S-nitrosoglutathione AND COMPOSITION MANUFACTURED BY THE SAME
KR1020107017003A KR101601989B1 (ko) 2008-01-16 2009-01-16 Ｓ-니트로소글루타티온의 안정화 방법 및 그 방법으로 제조된 조성물
BRPI0906874-0A BRPI0906874A2 (pt) 2008-01-16 2009-01-16 método para estabilização de s-nitrosoglutationa e composição preparada através do mesmo
US12/863,816 US8404266B2 (en) 2008-01-16 2009-01-16 Method for stabilization of S-nitrosoglutathione and composition prepared by the same
JP2010542695A JP5508286B2 (ja) 2008-01-16 2009-01-16 Ｓ−ニトロソグルタチオンの安定化方法、及び該方法により調製される組成物
PCT/HU2009/000004 WO2009090439A2 (en) 2008-01-16 2009-01-16 Method for stabilization of s-nitrosoglutathione and composition prepared by the same
CN2009801077972A CN101969922B (zh) 2008-01-16 2009-01-16 稳定s-亚硝基谷胱甘肽的方法和用该方法制备的组合物
PT97024228T PT2252260E (pt) 2008-01-16 2009-01-16 Método para estabilização da s-nitrosoglutationa e composições preparadas pelo mesmo
CN2013102937033A CN103417973A (zh) 2008-01-16 2009-01-16 稳定s-亚硝基谷胱甘肽的方法和用该方法制备的组合物
CA2712299A CA2712299C (en) 2008-01-16 2009-01-16 Method for stabilization of s-nitrosoglutathione and composition prepared by the same
HK11108321.0A HK1153944A1 (en) 2008-01-16 2011-08-09 Method for stabilization of s-nitrosoglutathione and composition prepared by the same
HRP20150578TT HRP20150578T1 (hr) 2008-01-16 2015-05-29 Metoda za stabilizaciju s-nitrozoglutationa i sastav pripremljen tom metodom
CY20151100493T CY1116359T1 (el) 2008-01-16 2015-06-03 Μεθοδος για σταθεροποιηση s-νιτροζογλουταθειονης και συνθεση που παρασκευαζεται με αυτην

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0800031A HU0800031D0 (en) 2008-01-16 2008-01-16 Method for stabilization of s-nitrosoglutathione and composition prepared by the same

Publications (1)

Publication Number Publication Date
HU0800031D0 true HU0800031D0 (en) 2008-03-28

Family

ID=89988005

Family Applications (2)

Application Number Title Priority Date Filing Date
HU0800031A HU0800031D0 (en) 2008-01-16 2008-01-16 Method for stabilization of s-nitrosoglutathione and composition prepared by the same
HUE09702422A HUE025573T2 (hu) 2008-01-16 2009-01-16 Eljárás s-nitrozoglutation és az eljárással elõállított készítmény

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE09702422A HUE025573T2 (hu) 2008-01-16 2009-01-16 Eljárás s-nitrozoglutation és az eljárással elõállított készítmény

Country Status (16)

Country Link
US (1) US8404266B2 (hu)
EP (1) EP2252260B1 (hu)
JP (1) JP5508286B2 (hu)
KR (1) KR101601989B1 (hu)
CN (2) CN101969922B (hu)
BR (1) BRPI0906874A2 (hu)
CA (1) CA2712299C (hu)
CY (1) CY1116359T1 (hu)
DK (1) DK2252260T3 (hu)
ES (1) ES2538338T3 (hu)
HK (1) HK1153944A1 (hu)
HR (1) HRP20150578T1 (hu)
HU (2) HU0800031D0 (hu)
PL (1) PL2252260T3 (hu)
PT (1) PT2252260E (hu)
WO (1) WO2009090439A2 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009050527A1 (en) * 2007-10-17 2009-04-23 Biotech Hungary Kutató És Fejlesztési Kft. Pharmaceutical composition comprising s-nitrosoglutathione and polysaccharide
CN101897948B (zh) * 2010-07-16 2013-03-13 浙江大学 一种s-亚硝基谷胱甘肽的用途
KR101555523B1 (ko) * 2014-02-28 2015-09-25 부산대학교 산학협력단 산화질소 방출성 상처치료 필름 및 이의 제조방법
CN106689132A (zh) * 2016-12-30 2017-05-24 中国农业科学院麻类研究所 一种提高红麻幼苗期耐镉性能的组合物
CN107823627A (zh) * 2017-12-01 2018-03-23 成都卓阳生物科技有限公司 一种还原型谷胱甘肽在制备治疗糖尿病足涂沫药剂中的应用
WO2019236825A1 (en) * 2018-06-08 2019-12-12 University Of Georgia Research Foundation, Inc. Antimicrobial compositions with wound healing properties

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504350D0 (en) * 1995-03-04 1995-04-26 Sod Conseils Rech Applic Arginine derivatives
US20070185205A1 (en) * 2000-01-14 2007-08-09 Hunt John F Airway Alkalinization as Therapy for Airway Diseases
AU4757901A (en) * 2000-03-20 2001-10-03 Novovascular Inc Matrices containing nitric oxide donors and reducing agents and their use
US20020002136A1 (en) * 2000-06-28 2002-01-03 Hebert Rolland F. Salts of glutathione
CA2433582C (en) * 2001-01-02 2012-04-24 Fujisawa Pharmaceutical Co., Ltd. Peptides having inhibiting activity on the production of nitric oxide
EP1968664B1 (en) * 2005-12-02 2010-10-27 The Regents Of The University Of Michigan Polymer compositions, coatings and devices, and methods of making and using the same
WO2009050527A1 (en) * 2007-10-17 2009-04-23 Biotech Hungary Kutató És Fejlesztési Kft. Pharmaceutical composition comprising s-nitrosoglutathione and polysaccharide

Also Published As

Publication number Publication date
DK2252260T3 (en) 2015-06-08
PL2252260T3 (pl) 2015-08-31
JP2011509993A (ja) 2011-03-31
HRP20150578T1 (hr) 2015-08-14
PT2252260E (pt) 2015-07-09
CN101969922A (zh) 2011-02-09
US8404266B2 (en) 2013-03-26
EP2252260B1 (en) 2015-03-04
CN101969922B (zh) 2013-07-10
KR20100127206A (ko) 2010-12-03
WO2009090439A3 (en) 2009-11-26
WO2009090439A2 (en) 2009-07-23
CN103417973A (zh) 2013-12-04
CA2712299C (en) 2016-10-11
HK1153944A1 (en) 2012-04-20
JP5508286B2 (ja) 2014-05-28
US20110136910A1 (en) 2011-06-09
CY1116359T1 (el) 2017-02-08
EP2252260A2 (en) 2010-11-24
ES2538338T3 (es) 2015-06-19
HUE025573T2 (hu) 2016-04-28
BRPI0906874A2 (pt) 2019-02-19
CA2712299A1 (en) 2009-07-23
KR101601989B1 (ko) 2016-03-09

Similar Documents

Publication Publication Date Title
IL228897A0 (en) Stable antibody preparations and methods for their stabilization
HK1161272A1 (zh) 特異性調節的方法與成分
EP2262474A4 (en) METHOD AND COMPOSITIONS FOR WOUND HEALING
EP2361089A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE
HK1160728A1 (en) Stable insecticide compositions and methods for producing same
ZA200902374B (en) Compositions useful for the treatment of diabetes
EP2483362A4 (en) Fluoropropene compounds and compositions and methods using same
ZA201004854B (en) Compositions and methods containing fluorine substituted olefins
EP2523944A4 (en) COMPOUNDS AND COMPOSITIONS FOR IMPROVING COGNITION, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT
EP2320740A4 (en) PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR PRODUCING LOW IMPURITY CONCENTRATIONS THEREOF
HK1158522A1 (en) Composition and method for treatment of mrsa
EP2257569A4 (en) METHOD OF TREATMENT USING ANTIMICROBIAL COMPOSITION
ZA201106577B (en) Compounds and compositions for cognition-enhancement,methods of making,and methods of treating
EP2266626A4 (en) COMPOSITION FOR TOPICAL APPLICATION WITH A TRANSCRIPTION FACTOR DECOY AS AN ACTIVE SUBSTANCE
HK1153944A1 (en) Method for stabilization of s-nitrosoglutathione and composition prepared by the same
PL2320739T3 (pl) Kompozycje farmaceutyczne i sposoby ich stabilizowania
EP2285215A4 (en) NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREFOR AND METHOD OF USE THEREOF
EP2291284A4 (en) COMPOSITIONS FOR TREATING MATERIALS AND TREATMENT METHOD THEREFOR
EP2230271A4 (en) ADDITION TO POLYMERIZABLE COMPOSITION, POLYMERIZABLE COMPOSITION THEREOF AND USE OF POLYMERIZABLE COMPOSITION
IL212850A0 (en) Novel method for the preparation of granulates of active constituents, and granulates as obtained
HRP20150021T1 (en) Phenanthrenone compounds, compositions and methods
EP2243350A4 (en) AQUEOUS CRYOPROTECTIVE COMPOSITION AND METHODS FOR APPLICATION THEREOF
IL208957A0 (en) Pharmaceutical gallium compounds, composition and methods of preparation
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
EP2356986A4 (en) COMPOSITION FOR METABOLIC SYNDROME TREATMENT